6533b7dcfe1ef96bd1271fe3

RESEARCH PRODUCT

Rubinstein-Taybi syndrome (CREBBP, EP300)

Oliver BartschDidier LacombeMartine J. Van BelzenDorien J.m. PetersRaoul C.m. Hennekam

subject

Rubinstein-Taybi SyndromeGeneticsMutationRubinstein–Taybi syndromebiologymedicine.disease_causemedicine.diseaseCREB-Binding ProteinSensitivity and SpecificityMolecular biologyFrameshift mutationExonPredictive Value of TestsMutationClinical Utility Gene CardGeneticsmedicinebiology.proteinHumansMissense mutationCREB-binding proteinEP300E1A-Associated p300 ProteinGeneGenetics (clinical)

description

1.2 OMIM# of the disease180849.1.3 Name of the analyzed genes or DNA/chromosome segmentsCREBBP, EP300 (E1A binding protein p300).1.4 OMIM# of the genes600140 (CREBBP), 602700 (EP300).1.5 Mutational spectrumMainly frameshift, nonsense, splice site and missense mutations. Lessfrequently large deletions (one or more exons) and rarely balancedinversions and translocations. Mutations are heterozygous, and mosaicmutations have been described. At present, more than 100 pathogenicmutations are known for the two genes together, but mutations inEP300 are much less common (only 11 so far).

yearjournalcountryeditionlanguage
2011-01-31
10.1038/ejhg.2010.124https://pure.amc.nl/en/publications/rubinsteintaybi-syndrome-crebbp-ep300(77270528-53a0-42b8-b769-fa3392bd8c24).html